Pure Red-Cell Aplasia and Antierythropoietin Antibodies in Patients Treated with Recombinant ErythropoietinNicole Casadevall, Patrick Mayeux, J Nataf et al.|New England Journal of Medicine|2002Cited by 1.2k
Targeting glutaminolysis has antileukemic activity in acute myeloid leukemia and synergizes with BCL-2 inhibitionNathalie Jacque, Didier Bouscary, Anne Marie Ronchetti et al.|Blood|2015Cited by 383
Role of the PI3K/AKT and mTOR signaling pathways in acute myeloid leukemiaSophie Park, Didier Bouscary, Nicolas Chapuis et al.|Haematologica|2009Cited by 316
Role of the phosphatidylinositol 3-kinase/Akt and mTOR/P70S6-kinase pathways in the proliferation and apoptosis in multiple myelomaFrédéric Pène, Didier Bouscary, Yann-Érick Claessens et al.|Oncogene|2002Cited by 298
Inhibiting glutamine uptake represents an attractive new strategy for treating acute myeloid leukemiaLise Willems, Didier Bouscary, Alain Schmitt et al.|Blood|2013Cited by 286